3rd Quarter - Report
INTERNATIONAL MYELOMA FOUNDATION for INTERNATIONAL MYELOMA FOUNDATION
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Income
—
Expenses
$60,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 27, 2022 | $60,000 | Replaced |
| 3rd Quarter - Amendment | Dec 5, 2022 | $43,878 | Replaced |
| 3rd Quarter - Amendment | Dec 5, 2022 | $43,879 | Replaced |
| 3rd Quarter - Amendment | Dec 5, 2022 | $43,879 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
CDMRP
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELLE DOHENY | — |
| ROBIN R LEVY | — |
Health Issues HCR
Oral Parity; CDMRP; Cancer Research Funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIELLE DOHENY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.